Osiris Therapeutics Inc (NASDAQ:OSIR)

11.16
Delayed Data
As of Sep 21
 +0.16 / +1.45%
Today’s Change
4.20
Today|||52-Week Range
13.70
+86.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2017
Revenue and IncomeNet Revenues11.8M24.3M50.8M118.5M
 
 
 
 
 
Cost of Goods Sold1.8M6.1M8.9M32.0M
 
 
 
 
 
Depreciation And Amortization708.0K587.0K940.0K688.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.3M17.7M40.9M85.8M
 
 
 
 
 
General Expenses20.4M20.5M47.9M87.8M
 
 
 
 
 
Research And Development14.1M5.0M3.4M4.1M
 
 
 
 
 
Total Operating Expenses23.0M27.1M57.8M120.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.2M-2.8M-7.0M-2.0M
 
 
 
 
 
Extraordinary Credit0.00401.0K0.000.00
 
 
Extraordinary Charge0.00---401.0K0.00
 
 
Other Expenses49.0K13.0K-1.4M-645.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.1M-2.4M-8.8M-2.6M
 
 
 
 
 
Income Taxes-37.0K-1.3M-97.0K-1.4M
 
 
 
 
 
Discontinued Operations0.00-6.7M-1.1M10.0M
 
 
 
 
Extraordinary Items0.0049.4M0.000.00
 
 
Net Income-11.1M-7.8M-10.0M8.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.9M33.3M34.3M34.5M
 
 
 
 
 
Shares To Calculate EPS Diluted32.9M33.3M34.3M34.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34$1.25-$0.29$0.25
 
 
 
 
 
EPS Diluted-$0.34-$0.23-$0.29$0.25